Creative Planning’s Trinity Biotech TRIB Stock Holding History

Creative Planning’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-42	Closed	-$38K	–	3567
2017 Q2	$38K	Hold	42	–	–	﹤0.01%	2740
2017 Q1	$37K	Buy	42 +34	+425%	+$31.9K	﹤0.01%	2688
2016 Q4	$9K	Sell	8 -21	-72%	-$21.7K	﹤0.01%	3630
2016 Q3	$58K	Hold	29	–	–	﹤0.01%	2246
2016 Q2	$49K	Hold	29	–	–	﹤0.01%	2149
2016 Q1	$51K	Sell	29 -1	-3%	-$1.59K	﹤0.01%	2095
2015 Q4	$54K	Buy	30 +1	+3%	+$1.77K	﹤0.01%	2063
2015 Q3	$50K	Buy	+29	New	+$70K	﹤0.01%	2040
2015 Q2	–	Sell	-29	Closed	-$84K	–	2865
2015 Q1	$84K	Sell	29 -1	-3%	-$2.77K	﹤0.01%	1672
2014 Q4	$77K	Buy	30 +9	+43%	+$23.3K	﹤0.01%	1705
2014 Q3	$59K	Buy	21 +20	+2,000%	+$65K	﹤0.01%	1814
2014 Q2	$3K	Hold	1	–	–	﹤0.01%	3423
2014 Q1	$3K	Buy	+1	New	+$3.93K	﹤0.01%	3276

Other funds holding TRIB

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Creative Planning's TRIB Position: Q3 2017 in Review

Creative Planning sold out of Trinity Biotech (TRIB) in Q3 2017, closing a stake of 42 shares — an estimated $38K sold.

Creative Planning first reported a position in TRIB in Q1 2014 and held it in 13 quarters. The position peaked at $84K in Q1 2015. 52 funds tracked by Wall St. Rank hold TRIB as of Q3 2017.

Creative Planning reported no remaining Trinity Biotech position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 42 Trinity Biotech shares in Q3 2017, an estimated $38K.
Creative Planning first reported a position in Trinity Biotech in Q1 2014 and held it in 13 quarters.
Creative Planning's Trinity Biotech position peaked at $84K in Q1 2015.
52 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.